Back to Directory
Last Updated: 11/06/2026
30 Technology
London
Founded 2018
Nitric oxide therapeutics developer for infectious and respiratory disease
30 Technology is a clinical-stage biopharmaceutical company developing nitric oxide-generating therapies for the treatment of antimicrobial-resistant infections and chronic respiratory diseases.
The company’s proprietary platform enables controlled, sustained delivery of nitric oxide across inhaled, topical and powder formulations, supporting applications in respiratory, rare disease, animal health and ophthalmology.
30 Technology focuses on advancing next-generation antimicrobial and anti-infective therapies through clinical development and strategic partnerships.
In April 2023 the company divested its wound care assets to Convatec Group.